This legislative proposal aims to enhance the affordability of prescription drugs for Americans, particularly those enrolled in Medicare and individuals with private health insurance. It seeks to expand the drug price negotiation program, apply inflation rebates to drugs in the commercial market, and establish limits on out-of-pocket expenses for prescription medications. A key provision of the legislation is the expansion of the drug price negotiation program, increasing the number of drugs eligible for negotiation from 20 to 50.